Neal L Benowitz1,2, Shonul Jain3, Delia A Dempsey3,4, Natalie Nardone4, Gideon St Helen2,4, Peyton Jacob2,5. 1. Division of Clinical Pharmacology and Experimental Therapeutics, Medical Service, Departments of Medicine, and Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA. 2. Center for Tobacco Control Research and Education, Department of Medicine, University of California, San Francisco, CA. 3. Department of Pediatrics, University of California, San Francisco, CA. 4. Division of Clinical Pharmacology, Department of Medicine, University of California, San Francisco, CA. 5. Department of Psychiatry, University of California, San Francisco, CA.
Abstract
INTRODUCTION: Routine biochemical assessment of tobacco smoke exposure could lead to more effective interventions to reduce or prevent secondhand smoke (SHS)-related disease in adolescents. Our aim was to determine using urine cotinine (major nicotine metabolite) measurement the prevalence of tobacco smoke exposure among adolescents receiving outpatient care at an urban public hospital. METHODS: Surplus urine was collected in 466 adolescents attending pediatric or urgent care clinics at Zuckerberg San Francisco General Hospital, serving families with lower levels of income and education, in 2013-2014. The majority were Hispanic or African American. Urine cotinine cut points of 0.05 to 0.25 ng/ml, 0.25 to 30 ng/ml, and 30 ng/ml were used to classify subjects as light SHS or thirdhand smoke exposed, SHS or light/intermittent active users, and active tobacco users, respectively. RESULTS: Among subjects 87% were exposed, including 12% active smoking, 46% SHS and 30% lightly exposed. The SHS exposed group adjusted geometric mean cotinine values were significantly higher in African Americans (1.48 ng/ml) compared to other groups (0.56-1.13 ng/ml). CONCLUSIONS: In a city with a low smoking prevalence (12%), a large majority (87%) of adolescents seen in a public hospital clinic are exposed to tobacco. This is much higher than reported in national epidemiological studies of adolescents, which used a plasma biomarker. Since SHS is associated with significant respiratory diseases and parents and adolescents underreport exposure to SHS, routine biochemical screening should be considered as a tool to reduce SHS exposure. The clinical significance of light exposure needs to be investigated. IMPLICATIONS: Urine biomarker screening found that a large majority (87%) of adolescents treated in an urban public hospital are exposed to tobacco. Since SHS is associated with significant respiratory diseases and parents and adolescents underreport exposure to SHS, routine biochemical screening should be considered as a tool to reduce SHS exposure.
INTRODUCTION: Routine biochemical assessment of tobacco smoke exposure could lead to more effective interventions to reduce or prevent secondhand smoke (SHS)-related disease in adolescents. Our aim was to determine using urine cotinine (major nicotine metabolite) measurement the prevalence of tobacco smoke exposure among adolescents receiving outpatient care at an urban public hospital. METHODS: Surplus urine was collected in 466 adolescents attending pediatric or urgent care clinics at Zuckerberg San Francisco General Hospital, serving families with lower levels of income and education, in 2013-2014. The majority were Hispanic or African American. Urine cotinine cut points of 0.05 to 0.25 ng/ml, 0.25 to 30 ng/ml, and 30 ng/ml were used to classify subjects as light SHS or thirdhand smoke exposed, SHS or light/intermittent active users, and active tobacco users, respectively. RESULTS: Among subjects 87% were exposed, including 12% active smoking, 46% SHS and 30% lightly exposed. The SHS exposed group adjusted geometric mean cotinine values were significantly higher in African Americans (1.48 ng/ml) compared to other groups (0.56-1.13 ng/ml). CONCLUSIONS: In a city with a low smoking prevalence (12%), a large majority (87%) of adolescents seen in a public hospital clinic are exposed to tobacco. This is much higher than reported in national epidemiological studies of adolescents, which used a plasma biomarker. Since SHS is associated with significant respiratory diseases and parents and adolescents underreport exposure to SHS, routine biochemical screening should be considered as a tool to reduce SHS exposure. The clinical significance of light exposure needs to be investigated. IMPLICATIONS: Urine biomarker screening found that a large majority (87%) of adolescents treated in an urban public hospital are exposed to tobacco. Since SHS is associated with significant respiratory diseases and parents and adolescents underreport exposure to SHS, routine biochemical screening should be considered as a tool to reduce SHS exposure.
Authors: Catherine A Wassenaar; David V Conti; Soma Das; Peixian Chen; Edwin H Cook; Mark J Ratain; Neal L Benowitz; Rachel F Tyndale Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-10-02 Impact factor: 4.254
Authors: Maciej Lukasz Goniewicz; Mark D Eisner; Eduardo Lazcano-Ponce; Wioleta Zielinska-Danch; Bartosz Koszowski; Andrzej Sobczak; Christopher Havel; Peyton Jacob; Neal L Benowitz Journal: Nicotine Tob Res Date: 2011-01-21 Impact factor: 4.244
Authors: Andy Z X Zhu; Caroline C Renner; Dorothy K Hatsukami; Gary E Swan; Caryn Lerman; Neal L Benowitz; Rachel F Tyndale Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-01-31 Impact factor: 4.254
Authors: Neal L Benowitz; Katherine M Dains; Delia Dempsey; Brenda Herrera; Lisa Yu; Peyton Jacob Journal: Nicotine Tob Res Date: 2009-06-12 Impact factor: 4.244
Authors: Manuela Martins-Green; Neema Adhami; Michael Frankos; Mathew Valdez; Benjamin Goodwin; Julia Lyubovitsky; Sandeep Dhall; Monika Garcia; Ivie Egiebor; Bethanne Martinez; Harry W Green; Christopher Havel; Lisa Yu; Sandy Liles; Georg Matt; Hugo Destaillats; Mohammed Sleiman; Laura A Gundel; Neal Benowitz; Peyton Jacob; Melbourne Hovell; Jonathan P Winickoff; Margarita Curras-Collazo Journal: PLoS One Date: 2014-01-29 Impact factor: 3.240
Authors: Gabriela R Oates; William T Harris; Steven M Rowe; George M Solomon; Suranjana Dey; Aowen Zhu; Wynton C Hoover; Hector H Gutierrez Journal: Pediatr Infect Dis J Date: 2019-11 Impact factor: 2.129
Authors: Neal L Benowitz; John T Bernert; Jonathan Foulds; Stephen S Hecht; Peyton Jacob; Martin J Jarvis; Anne Joseph; Cheryl Oncken; Megan E Piper Journal: Nicotine Tob Res Date: 2020-06-12 Impact factor: 4.244
Authors: Neal L Benowitz; Natalie Nardone; Shonul Jain; Delia A Dempsey; Newton Addo; Gideon St Helen; Peyton Jacob Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-02-23 Impact factor: 4.254
Authors: James W Baurley; Christopher S McMahan; Carolyn M Ervin; Bens Pardamean; Andrew W Bergen Journal: Trends Mol Med Date: 2018-02-04 Impact factor: 11.951